A Study to Monitor Renal Transplant Rejection with Cell Free DNA


About this study

The purpose of this study is to develop a digital droplet PCR-based method to quantitate ccfDNA., and to establish ranges of donor ccfDNA that correspond to rejection status.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients, 18 years of age or older.
  • Renal transplant recipients undergoing renal biopsy to evaluate for graft function

Exclusion Criteria: 

  • Patients under 18 years of age.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ann Moyer, M.D., Ph.D.

Open for enrollment

Contact information:

Katelyn Reed B.S., M.H.S.



More information


Publications are currently not available